Literature DB >> 17433652

Genetic defects affecting lymphocyte cytotoxicity.

Alain Fischer1, Sylvain Latour, Geneviève de Saint Basile.   

Abstract

Cytolytic lymphocytes kill virus-infected cells as well as tumor cells by the exocytosis of the content of specialized secretory lysosomes at the immunological synapse (IS). Perforin and granzymes are the molecular effectors that induce rapid target cell death. Cytolytic T cells are activated by specific antigen recognition whereas the cytolytic activity of natural killer cells is initiated by specific activating receptors or combinations thereof and is inhibited by self MHC class I recognition. The cytolytic process has received considerable attention and can now be described as a multi-step process including cell activation, polarization of specialized lysosomes -- lytic granules -- toward the IS, tethering of the lytic granules to the plasma membrane, priming for fusion with the plasma membrane, effective fusion and release of granule content in the IS cleft, and death of the target. This is a highly flexible system that could enable a cytolytic cell to subsequently kill target cells bound at different sites around the effector cell. Cytolytic cells exert a second effector function consisting of the secretion of cytokines, notably interferon gamma. The latter secretory process functions independently from the exocytic pathway of the lytic granules.

Entities:  

Mesh:

Year:  2007        PMID: 17433652     DOI: 10.1016/j.coi.2007.04.006

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  26 in total

1.  Analysis of RAB27A gene in griscelli syndrome type 2: novel mutations including a deletion hotspot.

Authors:  Setareh Mamishi; Mohammad Hossein Modarressi; Babak Pourakbari; Banafshe Tamizifar; Fatemeh Mahjoub; Alireza Fahimzad; Soheila Alyasin; Mohamad Hassan Bemanian; Amir Ali Hamidiyeh; Mohammad Reza Fazlollahi; Mahmoud Reza Ashrafi; Anna Isaeian; Ghamartaj Khotaei; Mehdi Yeganeh; Nima Parvaneh
Journal:  J Clin Immunol       Date:  2008-03-19       Impact factor: 8.317

2.  Enumeration of cytotoxic CD8 T cells ex vivo during the response to Listeria monocytogenes infection.

Authors:  Dietmar M W Zaiss; Alice J A M Sijts; Tim R Mosmann
Journal:  Infect Immun       Date:  2008-08-04       Impact factor: 3.441

Review 3.  Disorders of lysosome-related organelle biogenesis: clinical and molecular genetics.

Authors:  Marjan Huizing; Amanda Helip-Wooley; Wendy Westbroek; Meral Gunay-Aygun; William A Gahl
Journal:  Annu Rev Genomics Hum Genet       Date:  2008       Impact factor: 8.929

4.  EBAG9 tempers lymphocyte killing activity.

Authors:  Gaël Ménasché; Geneviève de Saint Basile
Journal:  J Clin Invest       Date:  2009-07-20       Impact factor: 14.808

Review 5.  Line of attack: NK cell specificity and integration of signals.

Authors:  Yenan T Bryceson; Eric O Long
Journal:  Curr Opin Immunol       Date:  2008-04-23       Impact factor: 7.486

6.  Granzyme B is recovered by natural killer cells via clathrin-dependent endocytosis.

Authors:  Pan Li; Guoying Zheng; Yan Yang; Chunguang Zhang; Ping Xiong; Yong Xu; Min Fang; Zheng Tan; Fang Zheng; Feili Gong
Journal:  Cell Mol Life Sci       Date:  2010-05-07       Impact factor: 9.261

7.  Novel 47.5-kb deletion in RAB27A results in severe Griscelli Syndrome Type 2.

Authors:  Lisa M Vincent; Fred Gilbert; Jennifer I DiPace; Carla Ciccone; Thomas C Markello; Andrew Jeong; Heidi Dorward; Wendy Westbroek; William A Gahl; James B Bussel; Marjan Huizing
Journal:  Mol Genet Metab       Date:  2010-06-10       Impact factor: 4.797

Review 8.  Signal transduction during activation and inhibition of natural killer cells.

Authors:  Carsten Watzl; Eric O Long
Journal:  Curr Protoc Immunol       Date:  2010-08

Review 9.  Insights into NK cell biology from human genetics and disease associations.

Authors:  Stephanie M Wood; Hans-Gustaf Ljunggren; Yenan T Bryceson
Journal:  Cell Mol Life Sci       Date:  2011-08-27       Impact factor: 9.261

10.  The risk of hemophagocytic lymphohistiocytosis in Hermansky-Pudlak syndrome type 2.

Authors:  Birthe Jessen; Sebastian F N Bode; Sandra Ammann; Subarna Chakravorty; Graham Davies; Jana Diestelhorst; Melissa Frei-Jones; William A Gahl; Bernadette R Gochuico; Matthias Griese; Gillian Griffiths; Gritta Janka; Christoph Klein; Tamara Kögl; Karin Kurnik; Kai Lehmberg; Andrea Maul-Pavicic; Andrew D Mumford; David Pace; Nima Parvaneh; Nima Rezaei; Geneviève de Saint Basile; Annette Schmitt-Graeff; Klaus Schwarz; Gulsun T Karasu; Barbara Zieger; Udo Zur Stadt; Peter Aichele; Stephan Ehl
Journal:  Blood       Date:  2013-02-12       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.